Literature DB >> 3356460

Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

W W Karakawa1, A Sutton, R Schneerson, A Karpas, W F Vann.   

Abstract

Capsular types 5 and 8, which account for about 70% of Staphylococcus aureus strains isolated from the blood of patients, resisted in vitro phagocytosis by human polymorphonuclear leukocytes (PMN). Antisera and monoclonal antibody to type 5 and 8 capsular polysaccharides (CPS) induced type-specific in vitro phagocytosis of capsulated organisms by PMN. Antibodies directed against the O-acetyl moiety of the type 8 CPS were more effective in inducing phagocytosis of type 8 organisms by PMN. Either type-specific antiserum or monoclonal antibody reactive with the native O-acetylated type 8 CPS was most effective in inducing in vitro phagocytosis of type 8 organisms by PMN. These results provide further evidence that CPS of S. aureus are associated with host immunity to this organism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356460      PMCID: PMC259767          DOI: 10.1128/iai.56.5.1090-1095.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  STRUCTURAL STUDIES ON STAPHYLOCOCCAL POLYSACCHARIDE ANTIGEN.

Authors:  S HANESSIAN; T H HASKELL
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

Review 3.  Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.

Authors:  J B Robbins
Journal:  Immunochemistry       Date:  1978-11

4.  The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.

Authors:  C J Howard; A A Glynn
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

5.  Structural analysis of the cellular constituents of a fresh clinical isolate of Staphylococcus aureus, and their role in the interaction between the organisms and polymorphonuclear leukocytes in the presence of serum factors.

Authors:  W W Karakawa; D A Young; J A Kane
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  Existence of multiple immunodeterminants in the type-specific capsular substance of group B type Ia streptococci.

Authors:  J A Kane; W W Karakawa
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

8.  Immunochemical analysis of a Smith-like antigen isolated from two human strains of Staphylococcus aureus.

Authors:  W W Karakawa; J A Kane
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

9.  Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.

Authors:  B J Wilkinson; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

10.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03
View more
  56 in total

1.  Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.

Authors:  S Ouyang; S Sau; C Y Lee
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes.

Authors:  E Martin; S Bhakdi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

4.  MsaB activates capsule production at the transcription level in Staphylococcus aureus.

Authors:  Justin L Batte; Dhritiman Samanta; Mohamed O Elasri
Journal:  Microbiology       Date:  2016-01-18       Impact factor: 2.777

5.  Evaluation of capsular and acapsular strains of S. aureus in an experimental brain abscess model.

Authors:  Nilufer Esen; Gail Wagoner; Napoleon Philips
Journal:  J Neuroimmunol       Date:  2009-11-10       Impact factor: 3.478

6.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.

Authors:  Jong-Ho Lee; Na-Hyang Kim; Volker Winstel; Kenji Kurokawa; Jesper Larsen; Jang-Hyun An; Adnan Khan; Min-Young Seong; Min Ja Lee; Paal Skytt Andersen; Andreas Peschel; Bok Luel Lee
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  Molecular characterization of endocarditis-associated Staphylococcus aureus.

Authors:  Cara Nethercott; Amanda N Mabbett; Makrina Totsika; Paul Peters; Juan C Ortiz; Graeme R Nimmo; Geoffrey W Coombs; Mark J Walker; Mark A Schembri
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

10.  Novel antigens expressed by Aeromonas salmonicida grown in vivo.

Authors:  J C Thornton; R A Garduño; S J Carlos; W W Kay
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.